<DOC>
	<DOCNO>NCT00540059</DOCNO>
	<brief_summary>Purpose study evaluation QoL , tolerability use Zoladex 10,8 SafeSystem advance PCa naturalistic condition</brief_summary>
	<brief_title>Evaluation QoL , Tolerability Use Zoladex 10,8 SafeSystem Advanced PCa - German IPEP Trial</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Goserelin</mesh_term>
	<criteria>Patients PCa , treat Zoladex 10,8 SafeSystem base current SPC</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>Prostate carcinoma</keyword>
	<keyword>LHRH</keyword>
	<keyword>Zoladex</keyword>
</DOC>